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ABSTRACT
Calcium/calmodulin-dependent protein kinase II
(CaMKII) plays a central role in pathological
cardiac hypertrophy, but the mechanisms by
which it modulates gene activity in the nucleus to
mediate hypertrophic signaling remain unclear.
Here, we report that nuclear CaMKII activates
cardiac transcription by directly binding to chroma-
tin and regulating the phosphorylation of histone
H3 at serine-10. These specific activities are
demonstrated both in vitro and in primary neonatal
rat cardiomyocytes. Activation of CaMKII signaling
by hypertrophic agonists increases H3 phosphoryl-
ation in primary cardiac cells and is accompanied
by concomitant cellular hypertrophy. Conversely,
specific silencing of nuclear CaMKII using RNA
interference reduces both H3 phosphorylation and
cellular hypertrophy. The hyper-phosphorylation of
H3 associated with increased chromatin binding of
CaMKII occurs at specific gene loci reactivated
during cardiac hypertrophy. Importantly, H3 Ser-10
phosphorylation and CaMKII recruitment are
associated with increased chromatin accessibility
and are required for chromatin-mediated tran-
scription of the Mef2 transcription factor. Unlike
phosphorylation of H3 by other kinases, which regu-
lates cellular proliferation and immediate early gene
activation, CaMKII-mediated signaling to H3 is
associated with hypertrophic growth. These obser-
vations reveal a previously unrecognized function of
CaMKII as a kinase signaling to histone H3 and
remodeling chromatin. They suggest a new epigen-
etic mechanism controlling cardiac hypertrophy.
INTRODUCTION
Histones are major components of chromatin and
assemble with DNA to form nucleosomes, the basic unit
of chromatin in all eukaryotic cells (1). The N-terminal
‘tail’ domain of histones modulates chromatin architecture
through flexible contacts with DNA and adjacent nu-
cleosomes. These ‘tails’ are subjected to a variety of
post-translational modifications, including acetylation,
methylation, ubiquitination, SUMOylation and phos-
phorylation (2,3). These modifications are reversible and
take place sequentially or in combination to form a set of
indicators that provide a linkage between signal transduc-
tion and gene expression (2,4). Although the vast majority
of studies have established a central role of histone acetyl-
ation and methylation in the control of gene transcription,
histone phosphorylation is much less studied and under-
stood (5,6). The identification of the kinases responsible
for histone modifications is critical to understand regula-
tory processes governing gene expression in all cells. It has
become apparent that protein kinases not only target
cellular proteins, transcription factors and components
of the transcriptional machinery but also signal the chro-
matin to regulate various cellular processes, such as tran-
scription, mitosis, DNA damage and apoptosis (7) (for
review). For instance, histone H3 phosphorylation at
serine-10 (Ser-10) was originally associated with chromo-
some condensation during mitosis (7–9). Subsequently,
H3 Ser-10 phosphorylation was observed after growth
factor stimulation. Kinases phosphorylating H3 Ser-10
discovered so far include Rsk2, IKKa, Msk1, PIM1 and
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Akt (10–14) [for review (6)]. The rapid and transient H3
phosphorylation event correlates with activation of imme-
diate early genes, such as c-jun and c-fos, cytokine gene
activation and Myc-dependent transcription. Increased
accessibility to nuclear factors and remodeling of chroma-
tin were suggested as critical events linking H3 Ser-10
phosphorylation and transcription activation. Whether
additional enzymes such as calcium-regulated kinases act
as physiological histone H3 kinases to regulate gene
expression through chromatin modification remains
unknown.
Calcium/calmodulin-dependent protein kinases (CaMKs)
are ubiquitous serine/threonine protein kinases that phos-
phorylate specific substrates in different sub-cellular com-
partments (15–17). There they serve as mediators of
calcium signals to produce a multitude of cellular responses
ranging from gene regulation to synaptic function, muscle
contraction and apoptosis (15,16,18) (for reviews).
CaMKII, the major CaMK isoform in the adult heart, is
produced as a holo-enzyme after alternative splicing of four
genes a, b, g and d (15) that assemble as homo- or
heteromultimer of 8–12 subunits (16–18). Some of the alter-
natively spliced isoforms such as the dB contain a functional
nuclear localization signal that allows expression of the
enzyme in the nucleus, whereas other isoforms such as the
dC are strictly cytoplasmic. These CaMKIId isoforms have
established roles in cardiac pathologies (19–21). Increased
CaMKII activity has been detected in human failing hearts
(20), and protection against structural cardiac disease has
been observed after CaMKII inhibition (22). Mice express-
ing high-cardiac levels of CaMKIId develop hypertrophy
and dilated cardiomyopathy (22,24), whereas deletion of
CaMKIId in mouse heart results in attenuated pathological
cardiac hypertrophy (21). One mechanism involves specific
signaling to the class II histone deacetylase HDAC4 (25,26),
which leads to dissociation of HDAC4 from Mef2 factors,
subsequent nuclear export of HDAC4/HDAC5 complexes
and relief of Mef2 repression resulting in hypertrophic
growth (27–29). Although CaMKIIdB has been shown to
phosphorylate HDAC4, it is currently unknown whether
CaMK enzymes have histones as direct substrates.
Here, we report a new function of nuclear CaMKII that
directly signals to histone H3 and increases its phosphoryl-
ation at Ser-10 during cardiac hypertrophy. This modifica-
tion increases chromatin accessibility and is a pre-requisite
for the hypertrophic transcriptional response. This reveals
a previously unrecognized function of CaMKII enzyme as
histone H3 kinase and a new mechanism of transcriptional
control in the heart. Our findings also have important im-
plications for the treatment of cardiac disorders and other
pathologies involving CaMK enzymes.
MATERIALS AND METHODS
Primary neonatal rat cardiomyocytes isolation
and treatment
Primary neonatal rat cardiomyocytes were isolated
using Worthington Neonatal Cardiomyocytes System
(Worthington, USA) according to the manufacturer’s
instructions, which are described in detail in the
Supplementary Data.
Production of recombinant adenoviruses, infection and
purification of CaMKIId and CaMKIV
Recombinant adenoviruses expressing green fluores-
cent protein (GFP) (Ad-GFP), wild-type CaMKIIdB
(Ad-CaMKIIdB), inactive CaMKIIdB-K43A (Ad-
CaMKIIdB-K43A) and constitutively active CaMKIIdB-
T287D (Ad-CaMKIIdB-T287D) were produced using the
AdEASY Vector System as described previously (26,30).
Flag-HDAC4 and Flag-HDAC5 were described before
(26). Details of the protocols can be found in the
Supplementary Data. Constitutively ‘active’ CaMKIV
truncated at Leu 317 carrying a flag epitope was purified
using the same approach after transfection of COS7 cells.
Antibodies
Antibodies used for western blot, immunoprecipitation,
chromatin immunoprecipitation and immunofluorescence
were as follows: Anti-HA probe (Y-11), anti-p-Histone H3
(Ser28), anti-Histone H2B (N-20), anti-p-CaMKIId and
anti-Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) antibodies were from Santa Cruz. Anti-p-
Histone H3 (Ser10) was from Santa Cruz, Sigma and
Invitrogen. Anti-a actinin was from Sigma. Anti-Histone
H3, anti-H3 (phospho T3) and (phospho T11) antibodies
were from Abcam. Anti-p-CaMKII (T286) was from Cell
Signaling. Anti-CaMKIId–specific antibody was a gift
from Dr Donald Bers (University of California Davis,
California). Ki67 and BrdU were from Abcam, UK.
Generation of mutant histone H3 S10A and
CaMKIIdB-"360-530
Mammalian expression vector for histone H3 was
described before (31). H3 cDNA was inserted in the
NotI/EcoRI site of pIRESneo (Clontech) also carrying a
Flag and an HA tag. Mutant histone H3 carrying S10A
substitution was generated by site-directed mutagenesis
using the GENEART system (Invitrogen). The mutation
was confirmed by restriction digestion and by DNA
sequencing. Three individual clones carrying the S10A
mutation were selected for further analysis. CaMKIIdB-
360-530 lacking the association domain was generated
by polymerase chain reaction (PCR) and was verified by
restriction digest and by sequencing. Briefly, CaMKIIdB-
360-530 was created by PCR performed from HA-
CaMKIIdB inserted into SR-alpha vector between PstI
and KpnI restriction sites. The primers were designed to
delete the association domain and retain the HA tag
(forward primer: TAC CGA AGC TGG TGG TGG
ACG TGG GCC AAG TGG, reverse primer: GAG
CAT CGG TCG TAT CAA CAG). The PCR product
generated was then inserted into SR-alpha vector.
Mass spectrometry
Large-scale primary neonatal rat cardiomyocyte cultures
were infected with inactive Ad-CaMKIIdB-K43A or
control Ad-GFP. Nuclear extracts were prepared, and
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after binding of cellular proteins to HA resin and washing,
proteins ‘trapped’ on CaMKIIdB-K43A were eluted with
HA peptide. The identity of the proteins that form a
complex with CaMKIIdBK43A was revealed by mass
spectrometry by comparing mass values with theoretical
values from protein sequence databases. The analysis was




Indirect immunofluorescence studies were performed
using standard methods. After adenoviral infection or
siRNA transfection, nuclear or whole-cell extracts were
prepared from primary neonatal rat cardiomyocytes as
described previously (26). Details of the procedures can
be found in the Supplementary Data.
BrdU incorporation and immunocytochemistry
Primary neonatal rat cardiomyocytes were transfected with
siControl or siRNA against CaMKIIdB (siCaMKIIdB).
Twenty-four hours post-transfection, cells were treated
with 100 mM BrDU for 4 h and then treated with 100 mM
phenylephrine (PE) for 24 h followed by standard immuno-
cytochemistry. Briefly, cells were fixed using pre-cooled
70% ethanol and then treated with 4M HCl for 40min at
37C. In total, 0.1M borax buffer, pH 8.5, was then added
for 5min at room temperature to neutralize the reaction.
After blocking with 5% fetal calf serum, rabbit anti-BrdU
IgG (1/100) was incubated overnight at 4C. After washing,
cells were incubated in biotin-conjugated secondary
antibody (Vector, USA) at room temperature for 1 h.
Slides were developed with 3,30-diaminobenzidine
tetrahydrochloride (Vector, USA) and lightly counter-
stained with hematoxylin before mounting in vectashield
(Vector, USA). Slides were visualized with a Nikon Ti-E
microscope.
Chromatin preparation and immunoprecipitation
Chromatin was prepared as originally described (32).
Details of the procedure can be found in the
Supplementary Data. Briefly, primary cardiomyocytes or
confluent HeLa cells were washed in hypotonic buffer, and
released nuclei were centrifuged through a sucrose
cushion, and the pellet was re-suspended in hypotonic
buffer. Chromatin DNA was treated with micrococcal
nuclease, and after stopping the reaction, insoluble
material was removed by centrifugation. Fragmented
chromatin in the supernatant was analyzed by centrifuga-
tion through glycerol gradients. DNA fragments were
analyzed after de-proteinization of chromatin fragments
by agarose gel electrophoresis.
0W0 and 0W47 nucleosome assembly
Nucleosome arrays were assembled using the 601 Widom
nucleosome positioning DNA sequence with either no
linker DNA (0W0 template) or with 47 bp of linker
sequence on one side (0W47), or with histone octamers
purified from HeLa cells or primary cardiomyocytes.
After high- to low-salt dialysis, reconstituted nucleosomes
were analyzed by native polyacrylamide gel electrophor-
esis (PAGE). Electromobility shift assays (EMSA) were
performed with labeled 0W0 or 0W47 nucleosomes and
increasing concentrations of purified CaMKIIdB or
purified ISWI used as positive control. The procedures
are described in detail in the Supplementary Data.
In vitro phosphorylation assay
The 15 mM CaMKIIdB wild-type, kinase ‘dead’
CaMKIIdB-k43A, ‘active’ CaMKIV or Aurora B kinase
and 20 ng/ml histone octamers, dephosphorylated chroma-
tin, HDAC4 or HDAC5 were incubated in a kinase
reaction buffer containing 50mM piperazine-N,N0-bis(2-
ethanesulfonic acid), pH 7.0, 20mM MgCl2, 0.2mg/ml
bovine serum albumin, 50 mM adenosine triphosphate
(ATP), 5 mCi/ml (1 Ci=37 GBq) of [g-32P]ATP (3000–
6000Ci/mmol) and 1mM CaCl2. The reaction was
carried out at room temperature for 30min and
terminated by addition of cold 15% trichloroacetic acid.
Reactions were then analyzed by sodium dodecyl sulfate
(SDS)–PAGE followed by autoradiography or western
blotting using anti-H3 Ser-10 antibody.
Q-PCR
Q-PCR reactions were performed from chromatin tem-
plates after immunoprecipitation. Primers used for fetal
cardiac genes were specific for atrial natriuretic factor
(ANF) and b-myosin heavy chain (b-MHC).
Amplification was also carried out for cardiac a-actin
and GAPDH. Details of the protocol are available in
the Supplementary Data. Chromatin immunopre-
cipitation (ChIP)–Q-PCR data were calculated based on
the standard per cent input method (Life Technologies,
USA). Briefly, 1% of the input fraction was subjected to
immunoprecipitation followed by Q-PCR with the
indicated gene primers. The adjusted input was calculated
by subtracting the raw Ct to log2 of 100 (6.644). The
samples were expressed as per cent input by applying the
following formula: 100 2^(adjusted input sample Ct).
IgG values were calculated in the same way and sub-
tracted from the per cent input of the samples. Results
were expressed either corrected or non-corrected over
basal condition (serum-free).
siRNA and shRNA
siRNA and shRNA experiments were described before
(26). Briefly, primary neonatal rat cardiomyocytes treated
with 100 mM PE were transfected with siControl (siCt) or
siRNA against CaMKIIdB (sidB) from Dharmacon
(ThermoScientific, USA). Seventy-two hours post-trans-
fection, total cell lysates were prepared and analyzed by
western blot using anti-histone H3 Ser-10-specific
antibody. Duplicate of the cell extracts were analyzed
with anti-CaMKIIdB and GAPDH antibodies. For im-
munofluorescence experiments, primary cardiomyocytes
were transfected with siControl or siCaMKIIdB and
treated with PE. Double immunostaining was performed
with H3 Ser-10 and a-actinin antibodies to visualize
H3 phosphorylation in ventricular myocytes. For
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ChIP–Q-PCR experiments, primary cardiomyocytes were
infected with a mock lentivirus or the vector carrying sh-
CaMKIIdB for 24 h followed by PE treatment for add-
itional 24 h and standard ChIP–Q-PCR assay.
MNase digestion
Long oligo nucleosomes isolated from Cos-7 cells tran-
sected with a eukaryotic expression vector for either Flag-
H3 or Flag-H3 S10A were incubated with MNase at a final
concentration of (60U/ml) on ice for 15min. After
stopping the reaction by addition of stop buffer [250mM
ethylenediaminetetraacetic acid (EDTA) and 5% SDS], the
MNase-digested DNA was analyzed on 1.5% agarose gel.
Restriction enzyme accessibility assay
Octamers were reconstituted onto nucleosomes using 601
DNA template synthesized by PCR using Cy5 labeled
primers corresponding to 0W0 (upstream primer: CTGC
AGAAGCTTGGTCCC, downstream: ACAGGATGTA
TATATCTG) (33,34). Reconstitutions were performed at
1 mM concentration and pH 7.5 by stepwise dialysis from
2M NaCl or KCl to 0.85, 0.65, 0.5 and finally 0M.
Equimolar amounts (20 nM) of ISWI, CaMKIITMB
and CaMKIIdB-K43A were added to 10 ng of the cy5-
0W0 nucleosome template in the presence or absence of
2mM ATP in reaction buffer [13mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), pH 7.9, 3mM
Tris–HCl, pH 8.0, 60mM KCl, 9mM NaCl, 3mM
MgCl2, 6% glycerol, 0.6mM dithiothreitol (DTT) and
10mM CaCl2]. The binding reactions were then treated
with StyI for 30min at 30C. The proportion of DNA
cleaved assessed by electrophoresis on 6% urea polyacryl-
amide gel was quantified, and the values of three independ-
ent experiments of the remodeling assay measuring the
digested band intensity were calculated.
Gel shift assay
ISWI and CaMKIITMB were serially diluted to the con-
centrations indicated in the figures in 1 HEPES-
magnesium-acetate (HMA) buffer (20mM HEPES, pH
7.6, 25mM KOAc and 5mM MgAc) containing 0.1%
Tween-20. Binding reactions were done in a final volume
of 10 ml containing 0.5 HMA buffer, 0.1mg/ml bovine
serum albumin, 1mM DTT, 5mM 4-(2-Aminoethyl)
benzenesulfonyl fluoride hydrochloride and 30 nM Cy5-
labeled nucleosome or DNA. Reactions were allowed to
equilibrate on ice for 30min before electrophoresis on
0.5 Tris-Borate-EDTA native polyacrylamide (49:1)
gels at 150V for 60min at 4C. Gels were scanned on a
Typhoon laser scanner for the Cy5 signal and the nucleo-
some/DNA bands quantified in ImageQuant image
analysis software. Quantification of EMSA gels was per-
formed using Image Quant software. The signal of nucleo-
some/CaMKIIdB or nucleosome/ISW-bound fraction
(AB) and the signal of total nucleosome (Atot) were
quantified and the fraction bound (AB/Atot) calculated.
Dissociation constants (Kd) were calculated using the
standard formula: Kd= [A] [B]/[AB], where Kd is the
affinity constant, and [A], [B] and [AB] are the
concentrations of nucleosomes, enzymes and nucleo-
some/enzyme complex, respectively.
Core histone-binding assays
Individual core histones or assembled octamers (4mg)
were incubated with 10 ml of wild-type CaMKIIdB, kinase
‘dead’ CaMKIIdB-K43A or mutant CaMKIIdB-360-530
bound to HA beads, in 60 ml binding buffer (10mM Tris,
pH 7.5, 1mMMgCl2, 3mM DTT and 1% Ficoll) contain-
ing 75mM NaCl. The beads were pelleted, and the super-
natant was added to SDS sample buffer for electrophoretic
analysis. The beads representing the bound fraction were
re-suspended in 30 ml of SDS sample buffer. The bound and
supernatant fractions were analyzed on 4–12% SDS–
PAGE and revealed by Coomassie staining.
In vitro transcription assay with assembled chromatin
Transcription assay with reconstituted chromatin was
carried out as described previously (35). Mutant histone
H3 carrying Ser-10 to alanine substitution was produced
by using the GENEART site-directed mutagenesis system
(Invitrogen). Three colonies carrying the mutation were
selected and confirmed by sequencing. Histone H3 wild-
type or mutant H3 S10A were purified by Flag resine after
transfection in HeLa cells. Wild-type or mutant histone
H3 S10A was reconstituted as octamers with the other
core histones as described before. The DNA template
for the in vitro transcription assay contained multimerized
Mef2-response elements and was generated by excising the
3xMef2-binding sites from the 3xMef2–luciferase vector
by Nhe/SmaI-blunt double digestion. The Gal4BD was
excised from the pS2-G5ML vector by NheI/NcoI-blunt
double digestion and the 3xMef2 linearized fragment was
then inserted in pS2-G5ML to generate the pS2-3xMef2
vector. Chromatin reconstituted with wild-type or mutant
histone H3 S10A was incubated with CaMKIIdB and
HeLa nuclear extracts in the presence of g[32]P-ATP.
Transcription was measured by the formation of RNA
corresponding to the transcribed Mef2 from the DNA
template alone and from the DNA template reconstituted
with chromatin. In parallel, transcription was also
measured from endogenous HeLa reconstituted
chromatin.
Animals
Procedures to isolate primary neonatal rat cardiomyocytes
were performed under approved protocol (RAC# 2100
024) from the Office of Research Affairs at King Faisal
Specialist Hospital & Research Centre.
Statistical analysis
Statistical analyses were performed using Student t-Test.
P-values <0.05 were considered significant.
RESULTS
Nuclear CaMKIIdB binds to chromatin
To understand the final steps of the transcriptional
reprogramming occurring during cardiac hypertrophy,
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we precipitated proteins that form a complex with the
most abundant cardiac nuclear CaMKII, the dB
isoform. CaMKIIdB was made inactive by K43A substi-
tution to favor kinase:substrate interaction and was
overexpressed in primary cardiac cells using a recombin-
ant adenovirus (Supplementary Figure S1). Cellular
proteins binding to CaMKIIdB-K43A were purified by
immunochromatography on hemagglutinin (HA) affinity
gels. Analysis of the complex revealed the presence of
several proteins interacting with CaMKIIdB not present
in the control sample, whose identities were revealed by
mass spectrometry. Surprisingly, among the peptides pre-
viously not known to interact with CaMKII were histones
(Figure 1A). Western blot analysis performed from the
eluate used in the mass spectrometric analysis confirmed
these interactions of CaMKIIdB-K43A with several
histone proteins (Figure 1B). Subsequently, binding of en-
dogenous CaMKIIdB with histones was also validated by
immunoprecipitating endogenous histone H3 from cardiac
nuclear extracts followed by western analysis using anti-
CaMKIId antibody (Figure 1C and 1D). Thus,
CaMKIIdB forms a protein complex with histone
proteins in cardiac cells.
To further establish CaMKIIdB binding to histones, we
assessed in vitro binding of the kinase with chromatin
isolated from primary neonatal rat cardiomyocytes. The
integrity of cardiac chromatin was verified by MNase
digestion, which showed the expected laddering pat-
tern of fragmented nucleosomes on the DNA fiber
(Supplementary Figure S2A), and the four core histones
when chromatin was analyzed by SDS–PAGE
(Supplementary Figure S2B). After incubation of cardiac
chromatin with CaMKIIdB bound to HA beads, both the
supernatant and the eluted beads were analyzed by
western blot (Supplementary Figure S2C). The majority
of CaMKIIdB were detected in the ‘bound fraction’
(Figure 1E, lanes 2 versus 3), whereas chromatin
incubated with the beads alone showed minimal binding
and mostly remained in the supernatant (Figure 1E, lanes
4 versus 5).
To fully establish the binding of CaMKIIdB to chroma-
tin, we performed EMSA using reconstituted 0W47
mononucleosomes as substrates, in which the 601 nucleo-
some positioning sequence directs assembly of a nucleo-
some such that it is flanked by 47 bp of linker DNA on
one side (Supplementary Figure S3A). [g32P]-DNA and
Cy5-labelled 0W47 mononucleosome templates were
incubated with increasing amounts of HA-bound
CaMKIIdB or ISWI, a known chromatin remodeler that
binds nucleosomes (34). As expected, ISWI bound free
DNA and 0W47 nucleosomes in a dose-dependent
manner (Supplementary Figure S3B, lanes 1–4 and 9–11).
CaMKIIdB was unable to bind free DNA (Supplementary
Figure S3B, lanes 5–8) but bound 0W47 nucleosomes in a
dose-dependent manner (Supplementary Figure S3B, lanes
12–14). CaMKIIdB also associated with 0W0 nucleosomes,
which lack any linker DNA flanking sequence (Figure 1F,
lanes 4–6), whereas ISWI binding was specific for 0W47
nucleosomes (Figure 1F, lanes 1–3 versus 7–9) as
reported before (34). Next, we studied the stoichiometry
of CaMKIIdB binding to nucleosomes by performing
binding assays using 0W47 nucleosomes and a wide range
of enzyme concentration (0–80 nM). Increased CaMKIIdB
binding to nucleosomes was observed with increasing
amounts of CaMKIIdB (Supplementary Figure S4A).
Generation of a binding curve after quantitation of the
bound enzyme showed that ISWI followed a standard
Michaelis–Menten curve, whereas CaMKIIdB binding to
0W47 showed a sigmoidal pattern, consistent with a co-
operative binding. CaMKIIdB showed a slightly lower
affinity toward 0W47 compared with ISW (Kd=
37.5±1.74 nM for CaMKIIdB versus 23.33±3.15 nM
for ISWI) (Supplementary Figure S4A and B). The obser-
vation that CaMKIIdB failed to bind DNA
(Supplementary Figure S3) and had no preference toward
the linker DNA of nucleosomes (Figure 1F) suggests that
CaMKIIdB association with chromatin is mediated by
histones rather than by flanking DNA. Thus, CaMKIIdB
directly binds to mononucleosomes and nucleosome arrays
in vitro. The strong association between CaMKIIdB and
chromatin in vitro suggests that CaMKIIdB may play a
role in chromatin architecture in the heart.
The association domain of CaMKIIdB is required for its
interaction to nucleosomes
Next, we mapped the region of interaction between
CaMKIIdB and chromatin. For this, we generated a
CaMKII deletion mutant lacking the association domain
(CaMKIIdB-360-530) carrying an HA tag and per-
formed immunoprecipitation with the purified deletion
construct immobilized on HA agarose and individual
histones or histone octamers. We observed binding of
wild-type CaMKIIdB and kinase ‘dead’ CaMKIIdB-
K43A to free H3, with a minimal binding to H2A/H2B
(Supplementary Figure S5B, lanes 5–8). When histone
octamers were used in the binding reaction, wild-type
CaMKIIdB and kinase ‘dead’ CaMKIIdB-K43A bound
preferentially to H3 and minimally to H4. (Supplementary
Figure S5C, lanes 2–5). Mutant CaMKIIdB-360-530
failed to bind free histones (Supplementary Figure S5B,
lanes 9–10) or histones reconstituted as octamers
(Supplementary Figure S5C, lanes 6–7). These results
indicate that CaMKIIdB preferentially binds H3, and
that the association domain is critical for this interaction.
CaMKIIdB preferentially phosphorylates histone H3
The observation that CaMKIIdB interacts with chromatin
in vitro and in primary cardiomyocytes suggested to us
that histones maybe novel substrates of the kinase in
cardiac muscle. To test this hypothesis, we performed
in vitro kinase assays with purified constitutively active
CaMKIIdB-T287D (Supplementary Figure S1A–C) and
histones reconstituted as octamers in the presence of
[g32P] ATP. Among the four core histones, CaMKIIdB
preferentially phosphorylated histone H3 (Figure 2A).
The specificity of CaMKIIdB for histone H3 in the
context of chromatin was next assessed by performing
in vitro kinase reactions with CaMKIIdB and chromatin
isolated from primary neonatal rat cardiomyocytes sub-
jected to de-phosphorylation. Again, we observed that
CaMKIIdB preferably phosphorylates histone H3
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Figure 1. CaMKIIdB binds to cardiac chromatin in vitro and in primary cardiomyocytes. (A) Coomassie staining of proteins that interact with
inactive HA-tagged CaMKIIdB-K43A in cardiac cells, after immunoprecipitation of nuclear extracts using HA agarose affinity gels and analysis by
SDS–PAGE. Arrows indicate CaMKIIdB and the histone proteins later identified by mass spectrometry that co-migrate with purified histone
octamers. Asterisks show immunoprecipitated proteins at 150mM salt concentration in cells expressing CaMKIIdB-K43A or GFP. (B) Western
blot analysis showing interaction of CaMKIIdB-K43A with histone proteins after immunoprecipitation with HA affinity gels (n = 3). Purified
histone octamers were run in parallel as a positive control. (C) Interaction of endogenous histone proteins with endogenous CaMKIIdB shown after
immunoprecipitation of cardiac nuclear extracts with a-H3 or control IgG antibodies and immunoblotting using a CaMKIId-specific antibody.
(D) Reverse experiment where CaMKIId was immunoprecipitated first with anti-CaMKIId antibody, and the precipitated proteins were analyzed by
SDS–PAGE and immunoblotted with a-H3-specific antibody. Blots in C and D are representative of two independent experiments. (E) Western blot
analysis showing the fraction of cardio-chromatin that binds to CaMKIIdB attached to HA agarose or that remains in the supernatant (n=4).
Immunoblotting with anti-H2B and -HA antibodies from 1: input chromatin, 2: chromatin bound to HA-CaMKIIdB, 3: chromatin remaining in the
supernatant not bound to HA-CaMKIIdB, 4: chromatin bound to HA beads alone, 5: chromatin remaining in the supernatant not attached to HA
beads. (F) Representative EMSA with increasing concentration of purified CaMKIIdB and 0W0 or 0W47 mononucleosome templates followed by
native PAGE, n=3. Arrows indicates the position of ISWI or CaMKIIdB bound to mononucleosomes.
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Figure 2. CaMKIIdB specifically phosphorylates histone H3 in histone octamers and in chromatin. (A) In vitro kinase assay (n=3) with purified
constitutively active CaMKIIdB-T287D and reconstituted histone octamers in the presence of [g32P] ATP followed by SDS–PAGE and autoradiography.
Asterisks indicate phosphorylation of histone H3 by CaMKIIdB. (B) In vitro kinase assays with constitutively active CaMKIIdB-T287D and de-
phosphorylated chromatin after treatment with calf intestine alkaline phosphatase (CIAP), purified from neonatal rat cardiomyocytes and HeLa cells
in the presence of [g32P] ATP followed by SDS–PAGE (n=5). Asterisks indicate phosphorylated histone H3. Lane 1: input de-phosphorylated cardio-
chromatin, 2: input de-phosphorylated HeLa chromatin, 3: CaMKIIdB-T287D alone, 4: CaMKIIdB-T287D and de-phosphorylated cardio-chromatin, 5:
CaMKIIdB-T287D and de-phosphorylated HeLa chromatin. (C) Western blot analysis with phospho-H3 (Ser-10), phospho-H3 (Ser-28) or total H3-
specific antibodies after in vitro kinase assay with recombinant histone H3 and active CaMKIIdB-T287D (n=3). (D) Immunoblots after in vitro
phosphorylation assay with endogenous cardio-chromatin or chromatin de-phosphorylated by CIAP treatment in the presence of increasing amount
of CaMKIIdB-T287D enzyme, using anti-H3 Ser-10, -H2B and -HA antibodies (n=3). Lane 1: cardio-chromatin alone, 2: cardio-chromatin treated
with CIAP, 3–5: cardio-chromatin treated with CIAP incubated with different amounts of CaMKIIdB-T287D. (E) In vitro kinase assay in the presence
of [g32P] ATP after transfection of HeLa cells with CaMKIIdB-T287D and wild-type Flag-histone H3 or mutant histone H3 S10A and immunopre-
cipitation of isolated chromatin using Flag resins (n=3). Lane 1: Flag-H3 wild-type alone, 2: Flag-H3-S10A alone, 3: CaMKIIdB-T287D alone, 4: Flag-
H3 wild-type+CaMKIIdB-T287D, 5: Flag-H3-S10A+CaMKIIdB-T287D. (F) Immunoblots showing phosphorylation at Ser-10 of wild-type
Flag-histone H3 and three different H3 S10A mutants after transfection in HeLa cells and immunoprecipitation using Flag resins (n=3). Lane 1:
Flag H3 wild-type, 2: Flag-H3 wild-type treated with CIAP, 3–5: Flag-H3-S10A from three separate clones.
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indicating specificity of CaMKIIdB toward H3 and not
toward other histones (Figure 2B, lanes 4 and 5). Next,
we compared the kinetics of H3 phosphorylation with a
bona fide H3 kinase, Aurora B. In vitro kinase assay was
performed using increasing amounts of purified Aurora B
or CaMKIIdB and reconstituted nucleosomes. H3 was
phosphorylated by both kinases, although phosphoryl-
ation by Aurora B was more efficient than CaMKIIdB
(Supplementary Figure S6A–C). Next, we compared H3
phosphorylation by CaMKIIdB with a known CaMKIIdB
substrate, the histone deacetylase HDCA4. HDAC5,
which is related to HDAC4 but is a much weaker
CaMKIIdB target (26), was also used in parallel for the
phosphorylation reaction. In vitro phosphorylation assay
revealed that CaMKIIdB phosphorylate H3 to a level
similar to that observed when using HDAC4. As
reported before, CaMKIIdB did not potently phosphoryl-
ate HDAC5 (Supplementary Figure S6E). These results
indicate that CaMKIIdB has specificity toward H3.
As CaMKIIdB is a serine/threonine kinase, we sur-
veyed serines and threonines in the histone H3 ‘tail’ to
identify potential CaMKIIdB phosphorylation sites
(Supplementary Figure S7A). In vitro kinase reaction per-
formed with recombinant histone H3 and constitutively
active CaMKIIdB-T287D followed by western blot
showed preferentially intense phosphorylation of histone
H3 at serine-10 (Ser-10) (Figure 2C), a well-characterized
site that plays a role in mitosis (7–9) and in growth factor
stimulation in non-cardiac cells (6,11–14,36–38). Adjacent
Ser-28 showed no detectable signal (Figure 2C). Next, we
investigated whether CaMKIIdB targets Ser-10 in chro-
matin itself. Chromatin was heavily phosphorylated at
Ser-10 in primary cardiac cells and was first subjected to
de-phosphorylation reaction (Figure 2D, lane 1 versus 2).
Addition of constitutively active CaMKIIdB-T287D
increased phosphorylation of histone H3 at Ser-10, in a
dose-dependent manner (Figure 2D, lanes 3–5). The
robust phosphorylation signal observed in the presence
of the kinase suggests that Ser-10 is a major phosphoryl-
ation site. To confirm this, we generated mutant histone
H3 with Ser-10 to Ala substitution carrying a Flag epitope
and performed in vitro kinase assay in the presence of
[g32P] ATP and CaMKIIdB-T287D. Wild-type H3 was
heavily phosphorylated by CaMKIIdB-T287D as
expected, whereas mutant H3 S10A showed significantly
lower phosphorylation (Figure 2E). Next, we confirmed
that the S10A mutation effects phosphorylation by
CaMKIIdB by immunoblotting. HeLa cells were trans-
fected with Flag-H3 or Flag-H3 S10A, and western
analysis was carried out after immunoprecipitation with
Flag resine and in vitro phosphorylation in the presence of
CaMKIIdB. We observed intense phosphorylation of
Flag-H3, whereas mutant H3 S10A phosphorylation was
severely impaired (Figure 2F). To address the specificity of
CaMKIIdB for H3 and to exclude the possibility that H3
phosphorylation by CaMKIIdB is due to other kinases
purified in the immunoprecipitate, we compared H3 phos-
phorylation by wild-type CaMKIIdB, kinase ‘dead’
CaMKIIdB-K43A and by ‘active’ CaMKIV. H3 phos-
phorylation by wild-type CaMKIIdB was intense,
whereas phosphorylation by CaMKIIdB-K43A was
minimal as shown before. No phosphorylation of H3
was detected in the presence of ‘active’ CaMKIV, suggest-
ing specificity of H3 for CaMKII (Supplementary Figure
S6D). Thus, histone H3 is a novel bona fide CaMKII sub-
strate, and Ser-10 seems to be a predominant phosphoryl-
ation site.
Histone H3 phosphorylation is increased after
hypertrophic stimulation
CaMKIId is central to pathological hypertrophic signaling
pathways (21,23). Rapid (30min) and transient H3 Ser-10
phosphorylation has been reported in response to
mitogens in non-cardiac cells (10). Thus, we examined
H3 phosphorylation level after hypertrophic stimulation
in primary neonatal rat cardiomyocytes by testing the
impact of short-term treatment with the hypertrophic
agonist PE. Increased H3 Ser-10 phosphorylation was
detected as early as 1 h after PE treatment and paralleled
increased expression of a-actinin, a hallmark of sarcomere
re-organization during hypertrophic growth
(Supplementary Figure S7B). Temporal analysis of H3
phosphorylation by immunoblotting showed further
increase of H3 Ser-10 levels beyond 6 h of treatment
with PE or its close analog xylometazolin (XY). The phos-
phorylation signal reached its maximum at 24 h of stimu-
lation and coincided with increased CaMKIId activity and
cellular hypertrophy evidenced by enhanced a-actinin ex-
pression (Figure 3A and B and Supplementary Figure S8).
Phosphorylation of other amino acids present in the
histone H3 ‘tail’ such as Thr-3 and Thr-11 was very low
in cardiac cells and did not increase after treatment with
PE or XY further supporting that Ser-10 is a major phos-
phorylation site (Supplementary Figure S7C).
To establish the link between CaMKIIdB and H3 phos-
phorylation during cardiac hypertrophy, we reduced
CaMKIIdB expression in primary cardiac cells treated
with PE using siRNA oligonucleotides specific for the
dB isoform (26) and assessed H3 Ser-10 levels by immuno-
blotting. Downregulation of CaMKIIdB significantly
reduced PE-mediated phosphorylation of H3 Ser-10,
whereas GAPDH levels did not change (Figure 3C). We
then investigated whether specific reduction of CaMKIIdB
decreases H3 Ser-10 in ventricular myocytes. Double-
immunostaining with a-actinin and H3 Ser-10 antibodies
in ventricular myocytes transfected with siControl showed
H3 Ser-10-positive cells (35%), whereas signal was
strongly reduced (5%) in siCaMKIIdB transfected cells
(Figure 3D and E). As histone H3 phosphorylation at Ser-
10 correlates with mitotic activity, we investigated whether
the increase in H3 phosphorylation after hypertrophic
agonist treatment could reflect an increase in cellular
proliferation. Levels of several cell cycle-regulated
proteins including Cdk4, cyclin E and Cdc2 were relatively
low and remained mostly unchanged in primary cardi-
omyocytes treated with PE and XY (Figure 4A). Thus,
H3 Ser-10 phosphorylation in primary cardiomyocytes
stimulated with hypertrophic agonists seems to be linked
to cellular hypertrophy rather than mitotic activity. To
confirm this, we measured BrdU incorporation in cells
transfected with siControl or siCaMKIIdB using
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Figure 3. Increased histone H3 phosphorylation during hypertrophic stimulation. (A) Western analysis from primary cardiac cells stimulated with
PE and XY using anti-H3 Ser-10, p-CaMKII, a-actinin and GAPDH antibodies. This experiment was repeated three times with three independent
cardiomyocyte preparations. (B) Quantitation of A. SF: cells maintained in serum-free conditions. (C) Western blot analysis of cell extracts prepared
from primary cardiomyocytes treated with PE and transfected with control siRNA (siCt) or siRNA against CaMKIIdB (sidB), using a-histone H3
Ser-10 antibody. NT: non-transfected cells (n=3). (D) Specific silencing of CaMKIIdB by siRNA decreases H3 Ser-10 in ventricular myocytes
undergoing hypertrophy. Merge image showing decreased histone H3 phosphorylation in ventricular myocytes stimulated with PE for 24 h trans-
fected with siCaMKIIdB compared with siControl using indirect immunofluorescence. Nuclei are shown in blue with 40,6-diamidino-2-phenylindole
(DAPI) staining, histone H3 Ser-10 is in green. Ventricular cardiomyocytes stained with a-actinin antibody are shown in red. Arrows indicate the
nuclei of myocytes positive for H3 Ser-10 in siControl myocytes and arrowheads nuclei which are negative for H3 Ser-10 in ventricular myocytes
after CaMKIIdB knock-down. (E) Percentage of ventricular myocytes positive for H3 Ser-10. Quantitative analysis of B was done in five different
fields. *P< 0.05 using Student t-test.
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immunocytochemistry. Low BrdU staining was observed
in both siControl- and siCaMKIIdB-transfected cells.
Cardiac cells treated with serum showed a stronger
BrdU staining, which was used as a positive control
(Figure 4B). Expression of Ki67 proliferation marker
using immunofluorescence was low in PE-treated ventricu-
lar myocytes transfected with siControl or siCaMKIIdB,
indicating a lack of cellular proliferation in these cells
(Figure 4C). These results show H3 Ser-10
phosphorylation in ventricular myocytes with normal
CaMKIIdB expression undergoing hypertrophy,
although these cells have limited proliferative capacity.
They also show that CaMKIIdB knock-down reduces
H3 Ser-10 phosphorylation in ventricular myocytes.
Together, our results show that CaMKIIdB is required
for H3 phosphorylation at Ser-10. Our results suggest
that CaMKIIdB signaling to histone H3 may be a new
underlying mechanism controlling the transcriptional
Figure 4. H3 Ser-10 phosphorylation in ventricular myocytes is not associated with cellular proliferation. (A) Expression level of cell cycle proteins
and cycle-dependent kinases during hypertrophic stimulation. Immunoblots from primary cardiac cells stimulated with PE and XY using anti-Cdk4,
cyclin E, Cdc2 and GAPDH antibodies. This experiment was repeated twice in two independent cardiomyocyte preparations. SF: serum-free
conditions. (B) Immunocytochemistry for BrdU and immunofluorescence for Ki67 in primary neonatal rat cardiomyocytes treated with PE for
24 h after transfection with siControl or siCaMKIIdB. CS: cardiomyocytes treated with serum. For Ki67, nuclei are shown in blue with DAPI
staining, Ki67 is shown in red. Ventricular cardiomyocytes stained with a-actinin antibody are shown in green.
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reprogramming of fetal cardiac genes occurring during
pathological cardiac hypertrophy.
Hyper-phosphorylation of histone H3 and recruitment
of CaMKIIdB at fetal cardiac genes during
hypertrophic stimulation
The hypertrophic response is characterized by the re-
activation of cardiac genes normally expressed during
embryonic development, which results in ventricular re-
modeling and growth of the heart. To determine
whether the phosphorylation status of histone H3 is con-
sistent with the transcriptional reprogramming of fetal
cardiac genes during cardiac hypertrophy, we performed
ChIP followed by Q-PCR to evaluate H3 phosphorylation
and CaMKIIdB occupancy at regulatory regions of
known hypertrophy-related genes. Cardiac chromatin
isolated from primary cardiomyocytes either unstimulated
or stimulated with PE was immunoprecipitated with H3
Ser-10 or CaMKIId antibodies, and associated genomic
DNA was analyzed by Q-PCR using primers for two
genes re-expressed during cardiac hypertrophy, the ANF
and b-MHC and for two genes not regulated during
hypertrophic stimulation, cardiac a-actin and GAPDH.
Under basal condition, phosphorylation of H3 and
CaMKIIdB binding was detected at the a-actin and
GAPDH genes, whereas a weak signal was detected at
the two hypertrophic loci, ANF and b-MHC
(Supplementary Figure S9). After PE stimulation, H3
phosphorylation and CaMKIIdB binding remained the
same at the a-actin and GAPDH genes, whereas signals
increased dramatically at the ANF and b-MHC promoter,
reaching a maximum at 24 h. The marked increased signal
at hypertrophic gene loci was obvious when results were
expressed over basal condition (Figure 5B and C). Thus,
hypertrophic stimulation increases H3 phosphorylation
and CaMKIIdB binding at hypertrophic-sensitive genes,
whereas genes not regulated during cardiac hypertrophy
remain unchanged. To determine whether CaMKIIdB
plays a major role in H3 Ser-10 phosphorylation, we
reduced CaMKIIdB expression using a lentivirus express-
ing CaMKIIdB shRNA (Figure 5D) and performed
ChIP–Q-PCR after hypertrophic stimulation with PE.
Reduction of CaMKIIdB resulted in a marked decrease
in H3 Ser-10 phosphorylation at the ANF and b-MHC
promoters, whereas a-actin and GAPDH remained un-
changed (Figure 5E). Consistent with the downregulation
of CaMKIIdB, the kinase was not detected at hyper-
trophic genes (data not shown). These results indicate
that H3 hyper-phosphorylation and increased CaMKII
binding are mostly detected at hypertrophic gene loci
actively transcribed during cardiac hypertrophy, and
that CaMKIIdB plays an important role in H3 Ser-10
phosphorylation. All together, these results suggest a func-
tional link between CaMKII recruitment, H3 phosphoryl-
ation and transcriptional activation.
Nuclear CaMKII increases chromatin accessibility
and remodeling
The extent of DNA packaging into nucleosomes deter-
mines the condensation state of chromatin, which can be
‘opened/active’ or ‘condensed/inactive’. Transcriptional
activation often depends on remodeling of chromatin by
remodeling complexes that change the local chromatin
architecture to a more ‘open’ stage conducive for recruit-
ment of nuclear factors. To further define the mechanism
by which CaMKII-mediated signaling to H3 activates
cardiac transcription, we investigated whether chromatin
structure is altered by the S10 mutation in H3. For this,
we examined MNase-cleaved patterns of chromatin
reconstituted with Flag-H3 or mutant Flag-H3 S10A.
Both ectopic Flag-H3 and Flag-H3 S10A incorporated
into chromatin as shown by western blot analysis using
anti-Flag or anti-H3 antibodies (Figure 6A). We observed
efficient MNase digestion indicated by the release of small
fragments on Flag-H3-digested chromatin, whereas chro-
matin harboring mutant H3 S10A remained compact and
unaffected by MNase digestion as shown by the produc-
tion of fragments of mostly larger sizes (Figure 6B). These
results indicate that Ser-10 phosphorylation is crucial for
chromatin re-structuring. To investigate the importance of
CaMKIIdB in chromatin remodeling, we performed a
second assay, restriction enzyme accessibility assay. In
all, 601 Widom nucleosomal DNA were reconstituted
in vitro (Figure 6C) and treated with restriction endonucle-
ase StyI in the presence or absence of CaMKIIdB. Naked
DNA was cut effectively by StyI as expected, whereas the
enzyme failed to cut DNA in the absence of any remodeler
(Figure 6D, lanes 1–4). As anticipated, ISWI remodeling
complex remodeled chromatin efficiently in the presence
of ATP as shown by the presence of a partially digested
fragment after incubation with StyI (Figure 6D, lanes 5
versus 6). We observed significant nucleosome remodel-
ing in the presence of CaMKIIdB, but not with inactive
CaMKIIdB-K43A (Figure 6D, lanes 7–10 and Figure 6E).
These results indicate that CaMKIIdB is able to remodel
chromatin, and that this remodeling is dependent on its
kinase activity. Together, these results indicate that
CaMKIIdB alters chromatin conformation, and that its
remodeling activity requires its kinase domain.
Impaired Mef2-dependent transcription from chromatin
reconstituted with mutant H3 S10A
To establish the functional and causal link between H3
Ser-10 phosphorylation by CaMKIIdB, chromatin re-
modeling and transcription activation, we developed an
in vitro transcription system to measure transcription
rates using either DNA or chromatin templates that
were reconstituted with wild-type histone H3 or mutant
H3 S10A. The Mef2 transcription factor is a point of con-
version for many hypertrophic signaling pathways (39),
and CaMKIIdB activates Mef2-dependent transcription
in cardiac cells (26). Therefore, we generated DNA tem-
plates harboring Mef2-response elements and measured
rates of transcription with wild-type and mutant
reconstituted chromatin in the presence of CaMKIIdB
and nuclear extracts (Figure 7A and B). Transcription
from endogenous chromatin or chromatin reconstituted
with wild-type Flag-H3 was high in the presence of
CaMKIIdB, calcium and ATP, whereas transcription
from native DNA templates was dependent on the
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presence of CaMKIIdB (Figure 7C). When chromatin was
reconstituted with mutant H3 S10A, CaMKIIdB almost
failed to transcribe Mef2 (Figure 7D, lane 4 versus 6).
Theses results demonstrate that CaMKIIdB is critical for
Mef2 transcription from chromatin templates. They also
show that CaMKIIdB-mediated Mef2 transcription
requires phosphorylation at Ser-10. Together, these
results show that CaMKIIdB remodels chromatin
through phosphorylation of Ser-10, which is required for
the transcriptional activation of hypertrophic genes.
DISCUSSION
In cardiac muscle, CaMKIIdB is central to pathological
hypertrophic pathways (20,21,23). In this study, we dem-
onstrate a novel function of nuclear CaMKIIdB that in-
creases histone H3 phosphorylation and remodels
chromatin. We show that CaMKIIdB directly signals to
chromatin to regulate the transcription of genes required
for the hypertrophic response (Figure 8). This shows that
nuclear calcium regulates gene activity by direct signaling
to chromatin.
Figure 5. Increased histone H3 Ser-10 and CaMKIIdB recruitment at fetal-cardiac promoters during hypertrophic stimulation. (A) Primers used for
the amplification of hypertrophic genes after ChIP from primary cardiomyocytes stimulated with PE. Primer sets are specific for the ANF, b-MHC,
a-cardiac actin and GAPDH genes. Black boxes represent the position of the primers relative to the start of transcription. ChIP–Q-PCR assay using
(B) a-histone H3 Ser-10 or (C) CaMKIId antibodies to precipitate chromatin from primary neonatal rat cardiomyocytes maintained in serum-free
conditions or treated with PE for 6, 24 and 24 h. Results are expressed as % input over basal condition (serum-free treatment). Error bars represent
means±SD (n=3). **P< 0.001 PE versus serum free. (D) Western blot showing downregulation of CaMKIIdB using a lentivirus expressing
CaMKIIdB shRNA (sh-dB) compared with control GFP lentivirus (sh-Ct). NT: primary cardiomyocytes non-transduced. H3 Ser-10 expression
and GAPDH control are shown in parallel. (E) ChIP–Q-PCR performed with H3 Ser-10 antibody from primary cardiomyocytes expressing
CaMKIIdB shRNA (sh-dB) or a mock GFP lentivirus and stimulated with PE for 6, 24 and 48 h. Results represent the average of three independent
experiments and are expressed as % input over basal condition (serum-free–treated cells). *P< 0.05. Comparison was made between Sh-Ct and
Sh-dB for each time point.
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To understand the transcriptional reprogramming
taking place during cardiac hypertrophy, we purified
proteins that form a complex with CaMKIIdB, the most
abundant nuclear CaMKII in the adult heart. Histones
were found to precipitate with the kinase. Direct inter-
action between exogenous CaMKIIdB and reconstituted
histone octamers, and chromatin was demonstrated
in vitro. Subsequently, we showed a strong association of
endogenous or ectopically expressed CaMKIIdB with
chromatin in primary cardiac cells. Among the four core
histones, CaMKIIdB seems to markedly phosphorylate
histone H3 with minimal phosphorylation of H2A/H2B,
suggesting specificity of the kinase. Ser-10 is a major phos-
phorylation site, as mutation of this residue to alanine
abolishes phosphorylation by CaMKIIdB. Our results
also show that specific signaling of CaMKIIdB to
histone H3 at Ser-10 is critical for the activation of fetal
cardiac genes after hypertrophic stimulation. Activation
of cardiac hypertrophy by a-adrenergic agonists increases
global H3 phosphorylation at Ser-10. Conversely, specific
reduction of CaMKIIdB using RNA interference reduces
H3 Ser-10 level with concomitant inhibition of cellular
hypertrophy.
Unexpectedly, we found that Ser-10 is a critical amino
acid targeted by the kinase and that H3 Ser-10 phosphor-
ylation by CaMKIIdB is not associated with cellular pro-
liferation. Rather, H3 Ser-10 phosphorylation by
CaMKIIdB regulates growth by hypertrophy. H3 Ser-10
Figure 6. CaMKIIdB increases chromatin accessibility. (A) Flag-H3 and Flag-H3 S10A are efficiently incorporated into chromatin as measured by
western blot using anti-Flag or anti-H3 antibodies. (B) MNase digestion of chromatin reconstituted with Flag-H3 or mutant H3 S10A separated on
agarose gel by electrophoresis. The DNA fragments obtained after digestion show that chromatin reconstituted with H3 S10A is more compact than
wild-type H3. (C) Schematic illustration of the 601 Widom template used after reconstitution for restriction enzyme accessibility assays. Analysis of
nucleosomal DNA by native polyacrylamide gel electrophoresis showing successful reconstitution in vitro. (D) Restriction enzyme accessibility assay.
Similar amounts (20 nM) of ISWI (lanes 5–6), CaMKIIdB (lanes 7–8) and CaMKIIdB K43A were added to 10 ng of the 0W0 template in the
presence or absence 2mM ATP. The binding reactions were then treated with 10 U of StyI for 30min at 30C, and the proportion of DNA cleaved
was assessed by electrophoresis. (E) Quantification of three independent experiments of the remodeling assay measuring the digested band intensity.
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Figure 7. In vitro transcription assay with reconstituted chromatin and DNA templates with multimerized Mef2-binding sites. (A) DNA templates
harboring upstream multimerized Mef2-binding sites, the adenovirus major late promoter (MLP) in front of a G-less cassette, and 50 and 30 flanking
regions repeats of nucleosome positioning sequences. In vitro transcription was measured from chromatin templates reconstituted in vitro with wild-
type histone H3 or mutant histone H3 S10A after addition of active CaMKIIdB-T287D and nuclear extracts. (B) Agarose gel showing DNA
templates with multimerized Mef2-binding sites and chromatin reconstitution in vitro. (C) Transcription from chromatin reconstituted with histone
octamers and DNA templates harboring 3xMef2-binding sites in the presence of CaMKIIdB and nuclear extracts. (D) In vitro transcription assay
showing that CaMKIIdB-mediated chromatin transcription requires phosphorylation of histone H3 at Ser-10. Transcription from free Mef2 DNA
templates and endogenous HeLa chromatin or chromatin reconstituted with wild-type Flag-H3 or mutant Flag-H3 S10A was measured in the
presence of active CaMKIIdB-T287D, ATP, calcium and nuclear extracts.
Nucleic Acids Research, 2013, Vol. 41, No. 16 7669
phosphorylation was previously shown to play a dual role;
in mitosis where chromatin condenses and becomes silent,
and in interphase where chromatin decondenses for tran-
scriptional activation. Mitotic kinases that phosphorylate
histone H3 at Ser-10 include Aurora B (40) and NIMA
(7,9,41). Also, Snf1 (42), Jil-1 (43), Rsk2 (10), Msk1/2 (44),
protein kinase B (PKB)/Akt and PIM1 are mitogenic
kinases inducing a rapid and transient phosphorylation
of H3 in non-cardiac cells with an effect on a limited
number of immediate early genes. Based on these
reports, we investigated whether the marked increase in
H3 phosphorylation in hypertrophic cardiomyocytes
could reflect an increase in cellular proliferation.
Expression of one proliferation marker and several cell
cycle-regulated proteins was unchanged after hypertrophic
challenge, whereas histone H3 phosphorylation increased
dramatically. BrdU incorporation and expression of the
Ki67 remained very low in ventricular myocytes treated
with PE expressing normal or reduced CaMKIIdB.
Furthermore, phosphorylation of histone H3 by
CaMKIIdB was not as transient as H3 phosphorylation
by other H3 kinases. These observations underscore that
H3 Ser-10 has another function than the ‘classical’ mitotic
marker. Thus, it seems that the same ‘mark’ on histone H3
can drive both cellular proliferation and growth by
increase in cell size. The implication is that these processes
are controlled by distinct kinases. Another explanation is
that specificity of the signal comes from the assembly of
large transcriptional complexes that are different in
various cell types. These possibilities are currently under
investigation.
CaMKII is used as a non-specific H3 kinase in vitro. To
ascertain the efficiency of CaMKIIdB for H3, we per-
formed kinetic experiments with increasing amounts of
CaMKIIdB and compared H3 phosphorylation with an
established H3 kinase, Aurora B. CaMKIIdB was able
to phosphorylate H3, although not as efficiently as
Aurora B. We also compared H3 Ser-10 phosphorylation
by kinase ‘dead’ CaMKIIdB-K43A and CaMKIV.
Significant H3 Ser-10 phosphorylation was observed
with CaMKIIdB but not by kinase ‘dead’ CaMKIIdB
nor by CaMKIV. Specificity of CaMKIIdB for H3 in
cardiac cells was established by siRNA experiments and
by comparing phosphorylation of H3 to an established
CaMKIIdB substrate, HDAC4. H3 phosphorylation by
CaMKIIdB was similar to CaMKIIdB-mediated phos-
phorylation of HDAC4. Marked H3 phosphorylation
was observed in ventricular myocytes undergoing hyper-
trophy and expressing CaMKIIdB, whereas H3 Ser-10
was severely reduced in ventricular myocytes where
CaMKIIdB is knocked down. Thus, although phosphor-
ylation of H3 is not as high as with Aurora kinase,
CaMKIIdB specifically signals to H3 in cardiac cells
undergoing hypertrophy.
Mechanistically, we demonstrate a functional inter-
action between CaMKII-mediated signaling to H3
and transcription activation. Increased occupancy of
CaMKIIdB and hyper-phosphorylation of histone H3 at
Ser-10 are detected at the promoter region of fetal cardiac
genes after hypertrophic stimulation. A number of tran-
scriptional units examined showed binding of CaMKIIdB
and phosphorylation signal under basal conditions but
these remained unchanged after hypertrophic stimulation.
Specific elimination of CaMKIIdB severely impaired H3
Ser-10 at hypertrophic promoter regions, whereas genes
non-responsive to hypertrophy were minimally affected.
Therefore, CaMKIIdB targets histone H3 at specific
genomic loci, mostly those involved in regulating the ex-
pression of fetal cardiac genes. Thus, it seems that
CaMKIIdB not only signals to chromatin remodeling
enzymes like HDAC4 (25,26) but also to chromatin
itself. Our results show that signaling of CaMKIIdB to
H3 modulates chromatin architecture, as indicated by re-
striction enzyme digestion assay that shows increased
chromatin accessibility by CaMKIIdB. Importantly, the
effect of CaMKIIdB on chromatin structure depends on
its kinase activity, as a ‘kinase dead’ mutant enzyme has
no effect on chromatin conformation. Also, MNase diges-
tion of chromatin reconstituted with mutant H3 S10A
shows its high degree of condensation compared with
chromatin reconstituted with wild-type H3. One remain-
ing challenge in the ‘histone field’ is to establish the direct
link between histone modifications and their functional
consequences in vivo. In particular, these mutations are
usually lethal, and histone genes are represented as large
copy numbers in the genome making it a technical chal-
lenge to introduce specific mutations in selected organs to
study their impact in vivo. To establish the relationship
between H3 Ser-10 phosphorylation and transcriptional
activation, we developed an in vitro transcription assay
and measured transcription of Mef2 from chromatin
reconstituted with wild-type or mutant H3 in the
presence of CaMKIIdB. Strikingly, transcription rates
were severely reduced with chromatin reconstituted with
mutant H3 S10A compared with wild-type H3, indicating
that the Ser-10 site is critical for CaMKIIdB to properly
activate transcription. As Mef2 is a nodal point for many
hypertrophic signaling pathways (39), our results overall
Figure 8. Model of CaMKIIdB signaling to H3 and remodeling of
chromatin with subsequent transcriptional activation. Hypertrophic
stimulation increases CaMKIIdB expression in cardiac cells, which is
then recruited to hypertrophic gene loci and phosphorylates H3 at Ser-
10. This phosphorylation event remodels chromatin and allows the ac-
tivation of fetal cardiac genes. GTFs: general transcription factors,
PolII: RNA polymerase II.
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strongly suggest a causal link between H3 Ser-10 phos-
phorylation by CaMKIIdB and cardiac hypertrophy.
With the recent interest and rapid development of large-
scale genomic and epigenetic studies, ChIP experiments
followed by sequencing are underway and should
provide a clear insight on functional consequences
genome wide of chromatin remodeling and transcriptional
events controlled by CaMKIIdB. The study of CaMKIIdB
interaction with other chromatin modifiers, together with
experiments addressing the relationship between the
various histone modifications (i.e. methylation and acetyl-
ation) should also provide a deeper understanding of
underlying mechanisms regulating cardiac hypertrophy.
Considering the broad tissue distribution of CaMK
enzymes and their role in a variety of cellular functions,
our study provides a novel conceptual framework on the
functional role of CaMK enzymes as epigenetic modifiers.
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